Combination of Cryolipolysis and Aerobic Exercise in Reducing Abdominal Fat

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT05852652
Collaborator
(none)
40
1
1
2.4
16.9

Study Details

Study Description

Brief Summary

The purpose of the study is To investigate the adding effect of Cryolipolysis to aerobic exercise with low caliorie diet on waist-to-hip ratio , ultrasonography, body mass index and skin fold of subcutaneous fat tissue in abdominal adiposity in obese subjects

Condition or Disease Intervention/Treatment Phase
  • Device: cryolipolysis and aerobic exercise
N/A

Detailed Description

Obesity is a serious disease marked by an increase in body weight of at least 20% over the ideal weight due to an accumulation of body fat.

The prevalence of obesity has hit epidemic levels over the past few decades, and numerous obesity-related illnesses, including heart conditions, certain types of cancer, and diabetes, have risen concurrently. Weight loss through lifestyle modification, including a hypocaloric diet and/or increased physical exercise, along with behavioural techniques to support these changes, is the basis for treating or preventing these diseases through therapeutic intervention. Such methods rarely result in an obese person reaching a normal body weight because the typical weight reduction from lifestyle change is between 5 and 10% of baseline weight.

Recently, studies have used numerous devices, including cavitation, radiofrequency, cryolypolysis, and other many devices, according to the World Health Organization, to solve this issue.

The FDA has approved the cryolipolysis device for cutaneous cooling as well as a number of other uses. Cryolipolysis is a novel non-invasive technique for the selective reduction of fat cells with controlled, localised cooling.

Clinicians use the waist measurement and waist-to-hip ratio to assess abdominal obesity. These actions have a clear correlation to many vascular diseases, including atherosclerosis and the risk of developing acute coronary syndromes.

Typically, low-calorie diets are low in fat ( 30% of energy intake), high in carbohydrates (55-60% of total daily energy consumption), and energy-reduced (deficit of 2100-4200 kJ/d: ) minimum of 4200-5040 kJ/d for women and 5040- 5880 kJ/d for men) Due to the acutely high energy cost and ability to increase fat utilization, aerobic exercise is frequently recommended in conjunction with calorie restriction. Numerous studies examined the effects of modest caloric restriction alone or in combination with aerobic exercise.According to studies, a walk/jog programme enhanced body fat reduction compared to a group that only followed a diet.

There is a gap in the literature regarding combining cryolipolysis and aerobic exercise for losing weight, particularly abdominal adiposity, despite the fact that numerous studies have supported the efficacy of each on weight loss. Therefore, the goal of this research is to ascertain whether losing abdominal adiposity would be more successful when cryolipolysis and aerobic exercise were combined.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of Combination Between Cryolipolysis and Aerobic Exercise in Reducing Abdominal Adiposity in Obese Subjects
Actual Study Start Date :
Dec 12, 2022
Actual Primary Completion Date :
Feb 22, 2023
Actual Study Completion Date :
Feb 22, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: cryolipolysis and aerobic exercise

in this arm we combined between Three Max cool shaping Cryolipolysis device (ESM-8l00MO; EunSung global, Korea) was utilised. Vacuum controllable heads with cold temperatures ranging from (-10to 5)°C were adjusted according to each patient's tolerance, after careful patient sensation examination and vital sign evaluation before and after each session ,they got two sessions and walked from 30 to 60 minutes in nearby park.Two Cryolipolysis treatments totaling 45 minutes each were administered to each patient in the experimental group at the hypogastrium region, 5 cm below the umbilicus, using an anti-freezing membrane to prevent cold burn, in order to conduct the treatment

Device: cryolipolysis and aerobic exercise
the patients in this arm adjusted low calorie diet . According to the Recommended Dietary Intake (RDI), the low-calorie diet plan with three carefully calculated meals had a balanced macronutrient quantity of carbohydrate and protein, was low in fat, and was abundant in fruits, vegetables, and dietary fibres. they got two cryolipolysis sessions,one session in the month ,they got two sessions in two months,then took our outcome measures with walking 60 minutes in the park

Outcome Measures

Primary Outcome Measures

  1. the waist-to-hip ratio [2 months]

    by tape measurment

  2. abdominal skin fold [2 months]

    by fat caliper

  3. body mass index [2 months]

    by equation of world health organization

  4. fat thickness [2 months]

    by ultrasonography

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Body mass index of the subjects range from (30-40)kg/m2

  • subjects have abdominal adiposity

Exclusion Criteria:
  • patients with liver and kidney diseases

  • patients who have sensitivity to cold

  • patients who have auto-immune disease

  • patients after caesarean section

  • impaired peripheral circulation

  • Raynauds disease

  • pregnant or lactating women within 6 months

  • paroxysmal cold hemogobulinemia

  • individuals who had metabolic derangement such as type 2 dibetes

Contacts and Locations

Locations

Site City State Country Postal Code
1 Heba Ebrahim Elsayed Mohamed Cairo Egypt

Sponsors and Collaborators

  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Heba Ebrahim Elsayed Mohamed, the principle investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT05852652
Other Study ID Numbers:
  • cryolipolysis
First Posted:
May 10, 2023
Last Update Posted:
May 10, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Heba Ebrahim Elsayed Mohamed, the principle investigator, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 10, 2023